Combination chemotherapy with gemcitabine and cisplatin plus recombinant endostatin (endostar) and maintenance therapy with endostar in stage IIIB and IV NSCLC.
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Cisplatin; Endostatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Jan 2012 Status changed from recruiting to completed as reported by Chinese Clinical Trial Register record.
- 24 Jun 2009 New trial record